Scolaris Content Display Scolaris Content Display

Base de datos Cochrane de Revisiones Sistemáticas Protocolo - Intervención

Non‐nutritive sweeteners for diabetes mellitus

Declaraciones de intereses de los autores

Versión publicada: 27 noviembre 2017 Historial de versiones

https://doi.org/10.1002/14651858.CD012885

Esta versión no es la más reciente

ver la versión actual 25 mayo 2020

Contenido relacionado

Ir a:

Revisiones y protocolos relacionados

Respuestas clínicas Cochrane

Topics

Temas

Table 1. Acceptable daily intake levels of non‐nutritive sweeteners as defined by regulatory bodies

Sweetener

FDA (mg/kg body weight) (FDA 2015a)

SCF/EFSA (mg/kg body weight) (Mortensen 2006)

JECFA (mg/kg body weight) (JECFA 2010)

ACE‐K

15

9

15

Advantame

32.8

5

5

Aspartame

50

40

40

Cyclamate

Not approved

7

11

Luo han guo fruit extracts

Not specified

Not specified

Not specified

Neohesperidine DC

Not approved

5

Not evaluated

Neotame

0.3

2

2

Saccharin

15

5

5

Sucralose

5

15

15

Steviol glycosides

4

4

4

Thaumatin

Not approved

Not specified

Not specified

Note: aspartame and acesulfame moieties in aspartame‐acesulfame salt are covered by acceptable daily intake values established for aspartame and acesulfame potassium

ACE‐K: acesulfame potassium; DC: dihydrochalcone; EFSA: European Food Safety Authority;FDA: Food and Drug Administration; JECFA: Joint FAO/WHO Expert Committee on Food Additives; SCF: Scientific Committee on Food (European Commission)

Figuras y tablas -
Table 1. Acceptable daily intake levels of non‐nutritive sweeteners as defined by regulatory bodies
Ir a la tabla del protocolo